Treatment
Transarterial Chemoembolization (TACE)
4
Conditions
450
Trials
70K
Participants
54%
Average Safety
Condition Evidence
Liver cancer due to alcohol use
100 trials · 15K participants
70% effectiveness · 65% safety
Liver cancer due to hepatitis B
50 trials · 10K participants
75% effectiveness · 35% safety
Liver cancer due to hepatitis C
100 trials · 30K participants
70% effectiveness · 60% safety
Liver cancer due to NASH
200 trials · 15K participants
75% effectiveness · 55% safety